carbidopa has been researched along with methylphenidate in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (30.77) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (15.38) | 29.6817 |
| 2010's | 5 (38.46) | 24.3611 |
| 2020's | 2 (15.38) | 2.80 |
| Authors | Studies |
|---|---|
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Clineschmidt, BV; McGuffin, JC; Pflueger, AB; Totaro, JA | 1 |
| Ross, ED; Stewart, RM | 1 |
| Reimherr, FW; Wender, PH; Wood, DR | 1 |
| Camanni, F; Cocchi, D; De Leo, V; Genazzani, AR; Müller, EE; Murru, S | 1 |
| Delville, Y; Fleming, SM; Schallert, T | 1 |
| Bernardi, G; Federici, M; Geracitano, R; Mercuri, NB | 1 |
| Belagaje, SR; Buetefisch, CM; Haut, MW; Hobbs, G; Kesar, TM; Pergami, P | 1 |
| Ahsan, SA; Briggs, RG; Chendeb, K; Conner, AK; Jacobs, CC; Jones, RG; Nix, CE; Palejwala, AH; Sheets, JR; Sughrue, ME | 1 |
| Bachoud-Lévi, AC; Blasco-Amaro, JA; Capuano, A; Isabel-Gómez, R; Martín-Gómez, C; Nou-Fontanet, L; Ortigoza-Escobar, JD; Zorzi, G | 1 |
2 review(s) available for carbidopa and methylphenidate
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Systematic review of drug therapy for chorea in NXK2-1-related disorders: Efficacy and safety evidence from case studies and series.
Topics: Carbidopa; Chorea; Clonazepam; Humans; Levodopa; Methylphenidate; Tetrabenazine | 2023 |
2 trial(s) available for carbidopa and methylphenidate
| Article | Year |
|---|---|
An open clinical trial of L-dopa and carbidopa in adults with minimal brain dysfunction.
Topics: Adult; Attention Deficit Disorder with Hyperactivity; Carbidopa; Clinical Trials as Topic; Drug Combinations; Drug Evaluation; Drug Synergism; Female; Humans; Levodopa; Male; Methylphenidate | 1980 |
Effects of monoaminergic drugs on training-induced motor cortex plasticity in older adults.
Topics: Aged; Biogenic Monoamines; Biomechanical Phenomena; Carbidopa; Cross-Over Studies; Dextroamphetamine; Double-Blind Method; Drug Combinations; Electromyography; Evoked Potentials, Motor; Female; Humans; Levodopa; Male; Methylphenidate; Middle Aged; Motor Cortex; Motor Skills; Movement; Muscle, Skeletal; Neuronal Plasticity; Transcranial Magnetic Stimulation; Wrist | 2017 |
9 other study(ies) available for carbidopa and methylphenidate
| Article | Year |
|---|---|
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility | 2010 |
Fenfluramine-induced enhancement of confinement motor activity: an indirect 5-hydroxytryptamine-like action?
Topics: 5-Hydroxytryptophan; 5,6-Dihydroxytryptamine; Animals; Brain Chemistry; Carbidopa; Catecholamines; Cinanserin; Female; Fenclonine; Fenfluramine; Metergoline; Methylphenidate; Motor Activity; Rats | 1975 |
Akinetic mutism from hypothalamic damage: successful treatment with dopamine agonists.
Topics: Adult; Akinetic Mutism; Bromocriptine; Carbidopa; Ergolines; Humans; Hypothalamic Neoplasms; Hypothalamus; Levodopa; Male; Methylphenidate; Postoperative Complications | 1981 |
Dynamic tests of prolactin secretion in hyperprolactinemic states: carbidopa-L-dopa and indirectly acting dopamine agonists.
Topics: Adenoma; Adult; Carbidopa; Dopamine; Female; Humans; Kinetics; Levodopa; Methylphenidate; Nomifensine; Pituitary Neoplasms; Postpartum Period; Pregnancy; Prolactin | 1982 |
An intermittent, controlled-rate, slow progressive degeneration model of Parkinson's disease: antiparkinson effects of Sinemet and protective effects of methylphenidate.
Topics: Animals; Antiparkinson Agents; Behavior, Animal; Carbidopa; Cell Count; Differential Threshold; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Combinations; Drug Interactions; Drug Therapy, Combination; Immunohistochemistry; Levodopa; Male; Methylphenidate; Motor Activity; Movement; Nerve Degeneration; Neurons; Oxidopamine; Parkinson Disease; Parkinson Disease, Secondary; Rats; Rats, Long-Evans; Rotarod Performance Test; Substantia Nigra; Tyrosine 3-Monooxygenase | 2005 |
Actions of methylphenidate on dopaminergic neurons of the ventral midbrain.
Topics: Action Potentials; Adrenergic Uptake Inhibitors; Animals; Carbidopa; Central Nervous System Stimulants; Cocaine; Dopamine; Dopamine Antagonists; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Electric Stimulation; Enzyme Inhibitors; In Vitro Techniques; Membrane Potentials; Mesencephalon; Methylphenidate; Neural Inhibition; Neurons; Rats; Reserpine; Sulpiride | 2005 |
Neurochemical supplementation in patients with depressed levels of participation after brain tumor surgery: Rationale and preliminary results.
Topics: Adult; Basal Ganglia; Brain; Brain Neoplasms; Carbidopa; Dietary Supplements; Drug Combinations; Female; Frontal Lobe; Humans; Levodopa; Male; Methylphenidate; Middle Aged; Patient Participation; Postoperative Period; Retrospective Studies | 2020 |